Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients

Table 4

Comparison of NLR among total severe, mild patients, and healthy control.

Group study	NLR; Mean ± SD		Mean difference	95% CI of the difference
				Lower	Upper
Total severe patients	24.54 ± 2.4	0.0001	22.99	22.45	23.52
Mild patients	4.79 ± 1.2	0.0001	3.24	2.97	3.51
Severe 1 patients	24.54 ± 2.4	0.0001	22.99	22.45	23.52
Severe 2 patients	3.02 ± 1.30	0.0001	1.47	1.18	1.76
Healthy control	1.55 ± 0.56	0.0001	Cut-off	—	—

value is significant statistics at level <0.05. Data are presented as mean ± standard deviation. NLR: percentage of neutrophil lymphocytes; CI: confidence interval.